{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:07:10Z","timestamp":1791893230940,"version":"4.3.4"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023673","name":"Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008840","name":"Imam Muhammad Ibn Saud Islamic University","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2501"],"award-info":[{"award-number":["IMSIU-DDRSP2501"]}],"id":[{"id":"10.13039\/501100008840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enzyme and Microbial Technology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.enzmictec.2025.110657","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:25:37Z","timestamp":1744878337000},"page":"110657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comprehensive insights into carbonic anhydrase inhibition: A triad of In vitro, In silico, and In vivo perspectives"],"prefix":"10.1016","volume":"189","author":[{"given":"Ahmed A.","family":"Allam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Rudayni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris F.","family":"Aba Alkhayl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Mokhtar","family":"Lamsabhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-9564","authenticated-orcid":false,"given":"Emadeldin M.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.enzmictec.2025.110657_bib1","series-title":"Carbonic anhydrase inhibitors: an editorial","first-page":"677","author":"Supuran","year":"2013"},{"key":"10.1016\/j.enzmictec.2025.110657_bib2","article-title":"Multi-and poly-pharmacology of carbonic anhydrase inhibitors","author":"Supuran","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.enzmictec.2025.110657_bib3","series-title":"Molecular Characterization Purification and Immobilization of Bacterial Carbonic Anhydrase for Efficient CO2 Conversion","author":"Sharma","year":"2024"},{"key":"10.1016\/j.enzmictec.2025.110657_bib4","article-title":"Multiple binding modes of inhibitors to human carbonic anhydrases: an update on the design of isoform-specific modulators of activity","author":"D\u2019Ambrosio","year":"2024","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.enzmictec.2025.110657_bib5","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.enzmictec.2025.110657_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.136982","article-title":"Dynamic interactions and inhibitory mechanisms of Artemisia annua terpenoids with carbonic anhydrase IX","volume":"282","author":"Kamel","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.enzmictec.2025.110657_bib8","first-page":"1","article-title":"Insight on novel sulfamoylphenyl pyrazole derivatives as anticancer carbonic anhydrase inhibitors","author":"Ahmed","year":"2024","journal-title":"Mol. Divers."},{"issue":"12","key":"10.1016\/j.enzmictec.2025.110657_bib9","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00044-022-02978-9","article-title":"The potential of chalcone derivatives as human carbonic anhydrase inhibitors in the therapy of glaucoma","volume":"31","author":"Goci\u0107","year":"2022","journal-title":"Med. Chem. Res."},{"issue":"12","key":"10.1016\/j.enzmictec.2025.110657_bib10","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1016\/j.matt.2023.09.015","article-title":"Synthetic hydrogel polymer nanoparticles as a structural mimic of carbonic anhydrase","volume":"6","author":"Fan","year":"2023","journal-title":"Matter"},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural annotation of human carbonic anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131268","article-title":"Identification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II","volume":"267","author":"Rasheed","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib13","unstructured":"E. Zolotareva, N.M. Topchiy, N.F. Mykhailenko, O. Onoiko, Multiple Forms of Carbonic Anhydrase Activity in Leaves of Tetragonia Tetragonoides and the Impact of Heavy Metal Ions on the Enzyme Activity, Available at SSRN 4942999."},{"key":"10.1016\/j.enzmictec.2025.110657_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202401225","article-title":"Inhibition effects of some non-proteinogenic amino acid derivatives on carbonic anhydrase isoenzymes and acetylcholinesterase: an in vitro inhibition and molecular modeling studies","author":"Al\u0131m","year":"2024","journal-title":"Chem. Biodivers."},{"issue":"4","key":"10.1016\/j.enzmictec.2025.110657_bib15","first-page":"377","article-title":"In vivo changes in carbonic anhydrase activity and histopathology of gill and liver tissues after acute exposure to chlorpyrifos in rainbow trout","volume":"65","author":"Topal","year":"2014","journal-title":"Arch. Ind. Hyg. Toxicol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110159","article-title":"Synthesis of N-substituted 4-phenyl-2-aminothiazole derivatives and investigation of their inhibition properties against hCA I, II, and AChE enzymes","volume":"761","author":"Bi\u00e7er","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.enzmictec.2025.110657_bib17","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1080\/07391102.2023.2240889","article-title":"Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions","volume":"42","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.enzmictec.2025.110657_bib19","doi-asserted-by":"crossref","first-page":"1338528","DOI":"10.3389\/fmolb.2024.1338528","article-title":"Carbonic anhydrase, its inhibitors and vascular function","volume":"11","author":"Garc\u00eda-Llorca","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib20","first-page":"1","article-title":"Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery","author":"Capasso","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.enzmictec.2025.110657_bib21","series-title":"Altered Metabolism: A Major Contributor of Comorbidities in Neurodegenerative Diseases","first-page":"365","article-title":"Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases","author":"Thapliyal","year":"2024"},{"key":"10.1016\/j.enzmictec.2025.110657_bib22","first-page":"111","article-title":"GABAA-receptor signaling and ionic plasticity in the generation and spread of seizures","author":"Kaila","year":"2024","journal-title":"Jasper'S. Basic Mech. Epilepsies"},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12032-024-02313-9","article-title":"Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights","volume":"41","author":"Lagzian","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib24","doi-asserted-by":"crossref","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"issue":"48","key":"10.1016\/j.enzmictec.2025.110657_bib25","doi-asserted-by":"crossref","first-page":"35769","DOI":"10.1039\/D4RA06290F","article-title":"Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights","volume":"14","author":"Naeem","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.enzmictec.2025.110657_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/17460441.2024.2442739","article-title":"Novel Anticancer Drug Discovery Strategies Targeting Hypoxia-Inducible factors","author":"Mustafa","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17425255.2024.2328152","article-title":"Drug interactions of carbonic anhydrase inhibitors and activators","volume":"20","author":"Supuran","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150685","article-title":"Unraveling the mechanism of carbonic anhydrase IX inhibition by alkaloids from Ruta chalepensis: a synergistic analysis of in vitro and in silico data","volume":"733","author":"Alqhtani","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"45","key":"10.1016\/j.enzmictec.2025.110657_bib29","doi-asserted-by":"crossref","first-page":"33602","DOI":"10.1039\/D4RA05984K","article-title":"Mechanistic insights into carbonic anhydrase IX inhibition by coumarins from Calendula officinalis: in vitro and in silico approaches","volume":"14","author":"Alruhaimi","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.enzmictec.2025.110657_bib30","unstructured":"B. Siddiqui, C.S. Yadav, M. Akil, M. Faiyyaz, A.R. Khan, N. Ahmad, F. Hassan, M.I. Azad, M. Owais, M. Nasibullah, Artificial Intelligence in Computer-Aided Drug Design (CADD) Tools for the Finding of Potent Biologically Active Small Molecules, Available at SSRN 4752923."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/biomedicines12010201","article-title":"Anticancer drug discovery based on natural products: from computational approaches to clinical studies","volume":"12","author":"Chunarkar-Patil","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.enzmictec.2025.110657_bib32","series-title":"Synthesis and Applications in Chemistry and Materials: Volume 12: Enzymatic and Organic Systems","first-page":"39","article-title":"Paramagnetic NMR of Transition Metal Derivatives of Human Carbonic Anhydrase: Implications for Enzyme Catalysis and Sustainability","author":"Cerofolini","year":"2024"},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/md20110721","article-title":"Carbonic anhydrase inhibitors from marine natural products","volume":"20","author":"Supuran","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.enzmictec.2025.110657_bib34","author":"Ricci","year":"2023","journal-title":"Silico Methods Inhib. Bind. Anal. Hum. Carbon Anhydrase Isoforms Tyrosinase Enzym. Aimed Dev. N. Ther."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","article-title":"Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1113\/JP283579","article-title":"Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease","volume":"601","author":"Aspatwar","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib38","series-title":"Metalloenzymes","first-page":"139","article-title":"Chapter 3.1 - Carbonic anhydrases","author":"Supuran","year":"2024"},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic anhydrases - an overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","article-title":"Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity","volume":"125","author":"D\u2019Ambrosio","year":"2025","journal-title":"Chem. Rev."},{"issue":"17","key":"10.1016\/j.enzmictec.2025.110657_bib41","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1007\/s00018-018-2798-8","article-title":"Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX","volume":"75","author":"Langella","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib42","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","article-title":"Structure, function and applications of carbonic anhydrase isozymes","volume":"21","author":"Hassan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.ki.5002020","article-title":"The role of carbonic anhydrases in renal physiology","volume":"71","author":"Purkerson","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.enzmictec.2025.110657_bib44","series-title":"Carbonic anhydrases","first-page":"151","article-title":"Human carbonic anhydrases: tissue distribution, physiological role, and druggability","author":"Nocentini","year":"2019"},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib45","article-title":"Role of human carbonic anhydrase isoforms VA and VB in obesity: implications, mechanisms, and therapeutic prospects","volume":"28","author":"Ka\u00e7maz","year":"2024","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.enzmictec.2025.110657_bib46","first-page":"1","article-title":"Structure based exploration of mitochondrial alpha carbonic anhydrase inhibitors as potential leads for anti-obesity drug development","author":"Padhy","year":"2024","journal-title":"DARU J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.26599\/1671-5411.2024.11.005","article-title":"The role of acetazolamide in critical care and emergency medicine","volume":"21","author":"Giamello","year":"2024","journal-title":"J. Geriatr. Cardiol.: JGC"},{"key":"10.1016\/j.enzmictec.2025.110657_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189120","article-title":"Carbonic anhydrase IX: an atypical target for innovative therapies in cancer","author":"Ronca","year":"2024","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"9","key":"10.1016\/j.enzmictec.2025.110657_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300680","article-title":"Effective anticancer potential of a new sulfonamide as a carbonic anhydrase IX inhibitor against aggressive tumors","volume":"19","author":"Koyuncu","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.enzmictec.2025.110657_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2019.1623075","article-title":"Computational modeling of novel inhibitory peptides targeting proteoglycan like region of carbonic anhydrase IX and in vitro validation in HeLa cells","author":"John","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib51","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3390\/molecules23112911","article-title":"Carbonic anhydrase inhibitors as novel drugs against mycobacterial \u03b2-carbonic anhydrases: an update on in vitro and in vivo studies","volume":"23","author":"Aspatwar","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.enzmictec.2025.110657_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/bs.enz.2024.05.012","article-title":"Mycobacterial \u03b2-carbonic anhydrases: molecular biology, role in the pathogenesis of tuberculosis and inhibition studies","volume":"55","author":"Parkkinen","year":"2024","journal-title":"Bact. Carbon anhydrases"},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib53","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib54","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/13543776.2024.2397732","article-title":"Caspase inhibitors: a review on recently patented compounds (2016\u20132023)","volume":"34","author":"Kasana","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib55","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.jmedchem.3c01979","article-title":"SIRT3 Activation a promise in drug development? New insights into SIRT3 biology and its implications on the drug discovery process","volume":"67","author":"Lambona","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/ijms26010116","article-title":"Exploring the inhibition of toxoplasma gondii \u03b1-carbonic anhydrase by sulfonamides: insights into potential drug targeting","volume":"26","author":"Giovannuzzi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176677","article-title":"The potential of carbonic anhydrase enzymes as a novel target for anti-cancer treatment","author":"Xiao-Qun","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib58","series-title":"Carbonic anhydrase","first-page":"13","article-title":"Carbonic anhydrases: catalytic and inhibition mechanisms, distribution and physiological roles","author":"Supuran","year":"2004"},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib59","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.bmc.2012.08.019","article-title":"Insights towards sulfonamide drug specificity in \u03b1-carbonic anhydrases","volume":"21","author":"Aggarwal","year":"2013","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"De Luca","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib61","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.5c00509","article-title":"Synthesis of thiazole-methylsulfonyl derivatives, X-ray study, and investigation of their carbonic anhydrase activities: in vitro and in silico potentials","author":"Maryam","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.enzmictec.2025.110657_bib62","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","article-title":"Novel synthesized SLC-0111 thiazole and thiadiazole analogues: determination of their carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"87","author":"Abo-Ashour","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138161208783877956","article-title":"Anticonvulsant SUlfonamides\/sulfamates\/sulfamides with Carbonic Anhydrase Inhibitory Activity: Drug Design and Mechanism of Action","volume":"14","author":"Thiry","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1747-0285.2009.00857.x","article-title":"Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?","volume":"74","author":"Simone","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207417","article-title":"Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition","volume":"13","author":"Mboge","year":"2018","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/ar9501232","article-title":"Carbonic anhydrase:\u2009evolution of the zinc binding site by nature and by design","volume":"29","author":"Christianson","year":"1996","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.enzmictec.2025.110657_bib67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107609","article-title":"Deciphering molecular mechanisms underlying the inhibition of \u03b2-glucuronidase by xanthones from Centaurium spicatum","volume":"150","author":"Kamel","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.enzmictec.2025.110657_bib69","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1021\/acs.jmedchem.4c01555","article-title":"Inhibition of pseudomonas aeruginosa carbonic anhydrases, exploring ciprofloxacin functionalization toward new antibacterial agents: an in-depth multidisciplinary study","volume":"67","author":"Marinacci","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2024.2310777","article-title":"Synthesis of 4-sulfamoyl phenyl diazocarboxylic acid derivatives as novel non-classical inhibitors of human carbonic anhydrase II activity: an in vitro study","author":"Fatahian Bavandpour","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400548","article-title":"Cyclization of acyl thiosemicarbazides led to new helicobacter pylori \u03b1-carbonic anhydrase inhibitors","volume":"357","author":"Gumus","year":"2024","journal-title":"Arch. Der Pharm."},{"issue":"35","key":"10.1016\/j.enzmictec.2025.110657_bib72","doi-asserted-by":"crossref","first-page":"16429","DOI":"10.1039\/D3NJ02991C","article-title":"Mechanistic insights into chloramphenicol-mediated inactivation of cytochrome P450 enzymes and their active site mutants","volume":"47","author":"Kamel","year":"2023","journal-title":"N. J. Chem."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib73","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/cr900134a","article-title":"Application of metal coordination chemistry to explore and manipulate cell biology","volume":"109","author":"Haas","year":"2009","journal-title":"Chem. Rev."},{"issue":"21","key":"10.1016\/j.enzmictec.2025.110657_bib74","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.1021\/acs.chemrev.4c00517","article-title":"Evolution of copolymers of epoxides and CO2: catalysts, monomers, architectures, and applications","volume":"124","author":"Yang","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.enzmictec.2025.110657_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2024.107304","article-title":"Bridging in silico and in vitro perspectives to unravel molecular mechanisms underlying the inhibition of \u03b2-glucuronidase by coumarins from Hibiscus trionum","author":"Kamel","year":"2024","journal-title":"Biophys. Chem."},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib76","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib77","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1039\/D4RA09076D","article-title":"Multi-pronged molecular insights into flavonoid-mediated inhibition of squalene epoxidase: a pathway to novel therapeutics","volume":"15","author":"Kamel","year":"2025","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib78","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/acs.accounts.8b00570","article-title":"Allosteric methods and their applications: facilitating the discovery of allosteric drugs and the investigation of allosteric mechanisms","volume":"52","author":"Lu","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0115734080271639231030093152","article-title":"Recent advances in enzyme inhibition: a pharmacological review","volume":"20","author":"Singh","year":"2024","journal-title":"Curr. Enzym. Inhib."},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1529","article-title":"Rational design of allosteric modulators: Challenges and successes","volume":"11","author":"Chatzigoulas","year":"2021","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125558","article-title":"Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase","volume":"410","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib82","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s11064-021-03390-2","article-title":"Anticonvulsant effects of carbonic anhydrase inhibitors: the enigmatic link between carbonic anhydrases and electrical activity of the brain","volume":"46","author":"Ozsoy","year":"2021","journal-title":"Neurochem. Res."},{"issue":"19","key":"10.1016\/j.enzmictec.2025.110657_bib83","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/molecules24193580","article-title":"Extending the inhibition profiles of coumarin-based compounds against human carbonic anhydrases: synthesis, biological, and in silico evaluation","volume":"24","author":"Kartsev","year":"2019","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.enzmictec.2025.110657_bib84","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.3390\/molecules27227884","article-title":"Coumarin-based dual inhibitors of human carbonic anhydrases and monoamine oxidases featuring amino acyl and (pseudo)-dipeptidyl appendages: in vitro and computational studies","volume":"27","author":"Agamennone","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib85","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/14728222.2023.2263914","article-title":"An overview of novel antimicrobial carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib86","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/13543784.2024.2334714","article-title":"Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection","volume":"33","author":"Supuran","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.enzmictec.2025.110657_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/13543776.2024.2365407","article-title":"Biomedical applications of prokaryotic carbonic anhydrases: an update","author":"Capasso","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.enzmictec.2025.110657_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112930","article-title":"Carbonic anhydrase hybrid nanoflowers: from facile synthesis to their therapeutic prospects; the known, the unknown and the future","author":"Hayat","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"37","key":"10.1016\/j.enzmictec.2025.110657_bib89","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.2174\/0929867330666221128142730","article-title":"Recent advances in biological active sulfonamide based hybrid compounds part C: multicomponent sulfonamide hybrids","volume":"30","author":"Ghomashi","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib90","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijms17071150","article-title":"Non-classical inhibition of carbonic anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.enzmictec.2025.110657_bib91","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/156802607780636690","article-title":"Carbonic anhydrases as drug targets - an overview","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib92","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.enzmictec.2025.110657_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150685","article-title":"Unraveling the mechanism of carbonic anhydrase IX inhibition by alkaloids from Ruta chalepensis: a synergistic analysis of in vitro and in silico data","volume":"733","author":"Alqhtani","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.enzmictec.2025.110657_bib94","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib95","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.enzmictec.2025.110657_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107397","article-title":"Unveiling the tyrosinase inhibitory potential of phenolics from Centaurium spicatum: bridging in silico and in vitro perspectives","volume":"147","author":"Alruhaimi","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"47","key":"10.1016\/j.enzmictec.2025.110657_bib97","doi-asserted-by":"crossref","first-page":"47167","DOI":"10.1021\/acsomega.4c07624","article-title":"Integrating computational modeling and experimental validation to unveil tyrosinase inhibition mechanisms of flavonoids from alhagi graecorum","volume":"9","author":"Alruhaimi","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.enzmictec.2025.110657_bib98","doi-asserted-by":"crossref","first-page":"14236","DOI":"10.1039\/D4NJ02393E","article-title":"Unraveling molecular mechanisms of \u03b2-glucuronidase inhibition by flavonoids from Centaurea scoparia: integrated in silico and in vitro insights","volume":"48","author":"Alwaili","year":"2024","journal-title":"N. J. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib99","article-title":"Mechanistic Insights into \u03b2-glucuronidase inhibition by isoprenylated flavonoids from centaurea scoparia: bridging experimental and computational approaches","author":"Alwaili","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"30","key":"10.1016\/j.enzmictec.2025.110657_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202402129","article-title":"Exploring the inhibitory effects of quinolone medications on carbonic anhydrase enzyme activity: in vitro and in silico investigation","volume":"9","author":"Demir","year":"2024","journal-title":"ChemistrySelect"},{"issue":"30","key":"10.1016\/j.enzmictec.2025.110657_bib101","doi-asserted-by":"crossref","first-page":"21355","DOI":"10.1039\/D4RA03385J","article-title":"Design, synthesis, and in vitro and in silico studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitors","volume":"14","author":"Tasleem","year":"2024","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.enzmictec.2025.110657_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3063","article-title":"Carbonic anhydrase inhibition by antiviral drugs in vitro and in silico","volume":"36","author":"T\u00fcrke\u015f","year":"2023","journal-title":"J. Mol. Recognit."},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib103","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/ijms23052540","article-title":"Identification of novel and potent indole-based benzenesulfonamides as selective human carbonic anhydrase II inhibitors: design, synthesis, in vitro, and in silico studies","volume":"23","author":"Elkamhawy","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bioorg.2014.07.009","article-title":"Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies","volume":"56","author":"G\u00f6ksu","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113997","article-title":"Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold","volume":"228","author":"Krymov","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.enzmictec.2025.110657_bib106","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/antiox9090775","article-title":"In silico identification and biological evaluation of antioxidant food components endowed with human carbonic anhydrase IX and XII inhibition","volume":"9","author":"Costa","year":"2020","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib107","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00044-020-02696-0","article-title":"New amino acid clubbed Schiff bases inhibit carbonic anhydrase II, \u03b1-glucosidase, and urease enzymes: in silico and in vitro","volume":"30","author":"Rafiq","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.enzmictec.2025.110657_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103004","article-title":"Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"89","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.enzmictec.2025.110657_bib109","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.3390\/ijms23147950","article-title":"Novel INsights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies","volume":"23","author":"Pontecorvi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/14756366.2014.1003216","article-title":"Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II","volume":"31","author":"Ekhteiari Salmas","year":"2016","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103728","article-title":"Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors","volume":"98","author":"Moi","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"15","key":"10.1016\/j.enzmictec.2025.110657_bib112","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1080\/07391102.2021.1892527","article-title":"Investigation of in vitro and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II","volume":"40","author":"Camadan","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.enzmictec.2025.110657_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134783","article-title":"The synthesis, biological evaluation and in silico studies of asymmetric 3,5-diaryl-rhodanines as novel inhibitors of human carbonic anhydrase isoenzymes","volume":"1276","author":"Yararli","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"8","key":"10.1016\/j.enzmictec.2025.110657_bib114","first-page":"1027","article-title":"Azobenzenesulfonamide carbonic anhydrase inhibitors as new weapons to fight helicobacter pylori: synthesis, bioactivity evaluation","volume":"17","author":"Giampietro","year":"2024","journal-title":"Vivo Toxic. Comput. Stud."},{"key":"10.1016\/j.enzmictec.2025.110657_bib115","unstructured":"M. Khan, S.Ahsan Halim, N. Ur Rehman, A. Khan, S. Gibbons, R. Csuk, J. Uddin, A. Al-Harrasi, Novel Anti-Tumor Effect of Natural Products from Aloe vera Resin and their In-Vitro\/In-Silico Targeting Mechanism of Carbonic Anhydrase-II and IX, Chemistry & Biodiversity e202401978."},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103645","article-title":"Synthesis and inhibition profiles of N-benzyl- and N-allyl aniline derivatives against carbonic anhydrase and acetylcholinesterase \u2013 A molecular docking study","volume":"15","author":"Mahmudov","year":"2022","journal-title":"Arab. J. Chem."},{"issue":"32","key":"10.1016\/j.enzmictec.2025.110657_bib117","doi-asserted-by":"crossref","first-page":"28605","DOI":"10.1021\/acsomega.2c03528","article-title":"Synthesis, biological evaluation, and in silico studies of novel coumarin-based 4H,5H-pyrano[3,2-c]chromenes as Potent \u03b2-glucuronidase and carbonic anhydrase inhibitors","volume":"7","author":"Arif","year":"2022","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.enzmictec.2025.110657_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052205","article-title":"In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activity","volume":"7","author":"Stander","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.enzmictec.2025.110657_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136187","article-title":"Synthesis, single crystal XRD, in-silico and in-vitro studies of alkyl substituted acyl thiourea as carbonic anhydrase inhibitor","author":"Ahmed","year":"2023","journal-title":"J. Mol. Struct. 1292"},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/antiox10010056","article-title":"Dual carbonic anhydrase IX\/XII inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages","volume":"10","author":"Berrino","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.enzmictec.2025.110657_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2022.105125","article-title":"Commikuanoids A-C: new cycloartane triterpenoids with exploration of carbonic anhydrase-II inhibition from the resins of Commiphora kua by in vitro and in silico molecular docking","volume":"157","author":"Rehman","year":"2022","journal-title":"Fitoterapia"},{"key":"10.1016\/j.enzmictec.2025.110657_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128259","article-title":"Synthesis of new class of non-sulfonamide bis-benzimidazoles as antitumor agents by inhibiting carbonic anhydrase-IX enzyme","volume":"255","author":"Khan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032802","article-title":"Synthesis, biological and in silico studies of griseofulvin and usnic acid sulfonamide derivatives as fungal, bacterial and human carbonic anhydrase inhibitors","volume":"24","author":"Angeli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104554","article-title":"\u0130. Gul\u00e7in, Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and \u03b1-glycosidase enzymes","volume":"107","author":"Hashmi","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2021.107565","article-title":"Cholinesterases, carbonic anhydrase inhibitory properties and in silico studies of novel substituted benzylamines derived from dihydrochalcones","volume":"94","author":"Ak\u0131nc\u0131o\u011flu","year":"2021","journal-title":"Comput. Biol. Chem."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib126","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/biom12111696","article-title":"Design, synthesis, kinetic analysis and pharmacophore-directed discovery of 3-ethylaniline hybrid imino-thiazolidinone as potential inhibitor of carbonic anhydrase II: an emerging biological target for treatment of cancer","volume":"12","author":"Ahmed","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.enzmictec.2025.110657_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140937","article-title":"New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies","volume":"1325","author":"K\u00f6se","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.enzmictec.2025.110657_bib128","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11030-022-10527-0","article-title":"Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors","volume":"27","author":"Lolak","year":"2023","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14756366.2020.1713114","article-title":"Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation","volume":"35","author":"Fois","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134114","article-title":"Sulfonamide-phosphonate hybrids as new carbonic anhydrase inhibitors: In vitro enzymatic inhibition, molecular modeling, and ADMET prediction","volume":"1271","author":"Zareei","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"28","key":"10.1016\/j.enzmictec.2025.110657_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202401587","article-title":"New thiazole derivatives: carbonic anhydrase I\u2013II and cholinesterase inhibition profiles, molecular docking studies","volume":"9","author":"Karakaya","year":"2024","journal-title":"ChemistrySelect"},{"issue":"9","key":"10.1016\/j.enzmictec.2025.110657_bib132","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","article-title":"Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, in vitro, in vivo, and in silico investigations of coumarin-based thiazoles","volume":"67","author":"Hefny","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137277","article-title":"Targeting carbonic anhydrases II\/IX\/XII with novel series of coumarin-based compounds: synthesis, biological activity and molecular dynamics analysis","volume":"1300","author":"Takla","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib134","article-title":"Diuretic activity of ethanol extract of piper attenuatum leaves might be due to the inhibition of carbonic anhydrase enzyme: an in vivo and in silico investigation","volume":"4","author":"Sharma","year":"2024","journal-title":"Clin. Complement. Med. Pharmacol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116527","article-title":"A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments","author":"Hefny","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib136","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/0115734064310458240719071823","article-title":"A computational approach using \u03b1-carbonic anhydrase to find anti-trypanosoma cruzi agents","volume":"21","author":"Ortiz-P\u00e9rez","year":"2025","journal-title":"Med. Chem."},{"issue":"16","key":"10.1016\/j.enzmictec.2025.110657_bib137","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1080\/07391102.2022.2127905","article-title":"Synthesis of 4-hydroxy-L-proline derivatives as new non-classical inhibitors of human carbonic anhydrase II activity: an in vitro study","volume":"41","author":"Moghoufei","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib138","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bmc.2008.04.011","article-title":"Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions","volume":"16","author":"Massah","year":"2008","journal-title":"Biorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib139","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11696-023-03048-z","article-title":"Inhibitory effects of quercetin and resveratrol and their sulfonamide derivatives on the carbonic anhydrase activity: spectroscopic studies of the binding process","volume":"78","author":"Khateri","year":"2024","journal-title":"Chem. Pap."},{"key":"10.1016\/j.enzmictec.2025.110657_bib140","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijbiomac.2018.08.186","article-title":"Mechanistic investigation of sulfonamide ligands as human carbonic anhydrase II inhibitors","volume":"120","author":"Alaei","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.enzmictec.2025.110657_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200554","article-title":"Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif","volume":"356","author":"Demir","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.enzmictec.2025.110657_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137365","article-title":"New naphthoquinone thiazole hybrids as carbonic anhydrase and cholinesterase inhibitors: Synthesis, crystal structure, molecular docking, and acid dissociation constant","volume":"1301","author":"Efeoglu","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.enzmictec.2025.110657_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139472","article-title":"\u0131mo\u011fullar\u0131, \u0130. G\u00fcl\u00e7in, Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as multitarget acetylcholinesterase and carbonic anhydrase inhibitors","volume":"1319","author":"Mert","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.enzmictec.2025.110657_bib144","article-title":"Novel schiff base sulfonate derivatives as carbonic anhydrase and acetylcholinesterase inhibitors: synthesis, biological activity, and molecular docking insights","author":"Ya\u015far","year":"2024","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"47","key":"10.1016\/j.enzmictec.2025.110657_bib146","doi-asserted-by":"crossref","first-page":"46860","DOI":"10.1021\/acsomega.4c05804","article-title":"Novel dibenzoazepine-substituted triazole hybrids as cholinesterase and carbonic anhydrase inhibitors and anticancer agents: synthesis, characterization, biological evaluation, and in silico studies","volume":"9","author":"Erdo\u011fan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.enzmictec.2025.110657_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110099","article-title":"Dynamics of small molecule-enzyme interactions: novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes","volume":"759","author":"G\u00fcle\u00e7","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.enzmictec.2025.110657_bib148","doi-asserted-by":"crossref","first-page":"2300634","DOI":"10.1002\/ardp.202300634","article-title":"Synthesis and biological studies of pyrimidine derivatives targeting metabolic enzymes","volume":"357","author":"Korkusuz","year":"2024","journal-title":"Arch. Pharm."},{"issue":"27","key":"10.1016\/j.enzmictec.2025.110657_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202401093","article-title":"Investigation of some metabolic enzyme inhibition properties of novel chalcone-Cu complexes","volume":"9","author":"Ebiri","year":"2024","journal-title":"ChemistrySelect"},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300545","article-title":"Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions","volume":"357","author":"El Ati","year":"2024","journal-title":"Arch. Pharm."},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib151","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1080\/07391102.2023.2214224","article-title":"Design, synthesis, biological evaluation and docking analysis of pyrrolidine-benzenesulfonamides as carbonic anhydrase or acetylcholinesterase inhibitors and antimicrobial agents","volume":"42","author":"Poyraz","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib152","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1007\/s11030-023-10774-9","article-title":"Organohalogen chalcones: design, synthesis, ADMET prediction, molecular dynamics study and inhibition effect on acetylcholinesterase and carbonic anhydrase","volume":"28","author":"Aydin","year":"2024","journal-title":"Mol. Divers"},{"key":"10.1016\/j.enzmictec.2025.110657_bib153","first-page":"295","article-title":"12 Unlocking therapeutic potential: computational approaches for enzyme inhibition discovery","author":"Dar","year":"2024","journal-title":"Comput. Drug Discov.: Mol. Simul. Med. Chem."},{"issue":"14","key":"10.1016\/j.enzmictec.2025.110657_bib154","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.3390\/ijms23147950","article-title":"Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: design, synthesis, molecular modeling investigation, and biological studies","volume":"23","author":"Pontecorvi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"198","key":"10.1016\/j.enzmictec.2025.110657_bib155","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2022.0654","article-title":"An in silico model to study the impact of carbonic anhydrase IX expression on tumour growth and anti-PD-1 therapy","volume":"20","author":"Grajek","year":"2023","journal-title":"J. R. Soc. Interface"},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib156","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10426507.2024.2365702","article-title":"In silico and in vitro inhibition abilities of novel benzene sulfonamides on carbonic anhydrase and choline esterases","volume":"199","author":"Surgun","year":"2024","journal-title":"Phosphorus, Sulfur, Silicon Relat. Elem."},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib157","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1080\/07391102.2019.1623075","article-title":"Computational modeling of novel inhibitory peptides targeting proteoglycan like region of carbonic anhydrase IX and in vitro validation in HeLa cells","volume":"38","author":"John","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.enzmictec.2025.110657_bib158","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.3390\/ijms23095054","article-title":"Toward the discovery of a novel class of leads for high altitude disorders by virtual screening and molecular dynamics approaches targeting carbonic anhydrase","volume":"23","author":"Ali","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108969","article-title":"Dissecting molecular mechanisms underlying the inhibition of \u03b2-glucuronidase by alkaloids from Hibiscus trionum: Integrating in vitro and in silico perspectives","volume":"180","author":"Kamel","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib160","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-022-00437-x","article-title":"In silico prediction suggests inhibitory effect of halogenated boroxine on human catalase and carbonic anhydrase","volume":"20","author":"Corbo","year":"2022","journal-title":"J. Genet Eng. Biotechnol."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202402984","article-title":"Inhibitory mechanisms of \u03b2-glucuronidase by hibiscus syriacus phenolics: integrating computational and experimental approaches","volume":"10","author":"Alqhtani","year":"2025","journal-title":"ChemistrySelect"},{"issue":"35","key":"10.1016\/j.enzmictec.2025.110657_bib162","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1039\/D3OB01014G","article-title":"Mechanistic aspects of reactive metabolite formation in clomethiazole catalyzed biotransformation by cytochrome P450 enzymes","volume":"21","author":"Kamel","year":"2023","journal-title":"Org. Biomol. Chem."},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib163","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/molecules29071433","article-title":"Deciphering the molecular mechanisms of reactive metabolite formation in the mechanism-based inactivation of cytochrome p450 1b1 by 8-methoxypsoralen and assessing the driving effect of phe268","volume":"29","author":"Kamel","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.enzmictec.2025.110657_bib164","unstructured":"E.M. Kamel, S. Maodaa, E.M. Al-Shaebi, A. Mokhtar Lamsabhi, Molecular Insights Into \u03b2-Glucuronidase Inhibition by Alhagi Graecorum Flavonoids: A Computational and Experimental Approach, ChemistryOpen n\/a(n\/a) e202400325."},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib165","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1039\/D4MD00302K","article-title":"Design and synthesis of chromene-1, 2, 3-triazole benzene sulfonamide hybrids as potent carbonic anhydrase-IX inhibitors against prostate cancer","volume":"15","author":"Albelwi","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib166","article-title":"Synthesis of chromene-linked bis-indole derivatives as selective tumor-associated carbonic anhydrase ix inhibitors, anti-cancer","author":"Singh","year":"2024","journal-title":"Agents Med. Chem."},{"issue":"21","key":"10.1016\/j.enzmictec.2025.110657_bib167","doi-asserted-by":"crossref","first-page":"11644","DOI":"10.3390\/ijms252111644","article-title":"Carbon monoxide release from aryl-propargyl dicobalt (0) hexacarbonyl derivatives: a computational and experimental study","volume":"25","author":"Paciotti","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib168","author":"Le","year":"2024","journal-title":"A Rev. Ocul. Syst. Complicat. Glaucoma Pharmacother."},{"issue":"8","key":"10.1016\/j.enzmictec.2025.110657_bib169","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/metabo14080430","article-title":"Unraveling protein-metabolite interactions in precision nutrition: a case study of blueberry-derived metabolites using advanced computational methods","volume":"14","author":"Bhandari","year":"2024","journal-title":"Metabolites"},{"issue":"41","key":"10.1016\/j.enzmictec.2025.110657_bib170","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.2174\/0109298673249553231018070920","article-title":"Advances in the development of carbonic anhydrase inhibitors as new antiprotozoal agents","volume":"31","author":"Ortiz-Perez","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib171","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/14756366.2015.1113407","article-title":"Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors","volume":"31","author":"Di Cesare Mannelli","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib172","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41416-018-0216-5","article-title":"Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo","volume":"119","author":"Lee","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib173","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/ijms26010116","article-title":"Exploring the inhibition of toxoplasma gondii \u03b1-carbonic anhydrase by sulfonamides: insights into potential drug targeting","volume":"26","author":"Giovannuzzi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.enzmictec.2025.110657_bib174","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm900914e","article-title":"S-Glycosyl primary sulfonamides\u2212 A new structural class for selective inhibition of cancer-associated Carbonic Anhydrases","volume":"52","author":"Lopez","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib175","article-title":"Unveiling tomorrow: carbonic anhydrase activators and inhibitors pioneering new frontiers in Alzheimer's disease","author":"Mishra","year":"2024","journal-title":"Arch. Der Pharm."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib176","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","article-title":"Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies","volume":"37","author":"Kciuk","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib177","article-title":"CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma","volume":"5","author":"Jiang","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"22","key":"10.1016\/j.enzmictec.2025.110657_bib178","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/cells13221924","article-title":"Emerging role of extracellular ph in tumor microenvironment as a therapeutic target for cancer immunotherapy","volume":"13","author":"Rahman","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib179","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2024_240321N127","article-title":"Unlocking the paracrine crosstalk: adipocyte-derived factors affect carbonic anhydrase IX expression in colon and breast cancer cells","volume":"71","author":"Lapinova","year":"2024","journal-title":"Neoplasma"},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/14728222.2024.2369622","article-title":"Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes","volume":"28","author":"Gheibzadeh","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib181","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/pharmaceutics16020274","article-title":"Chemical insights into topical agents in intraocular pressure management: from glaucoma etiopathology to therapeutic approaches","volume":"16","author":"Patton","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-024-04154-x","article-title":"Advances in dorzolamide hydrochloride delivery: harnessing nanotechnology for enhanced ocular drug delivery in glaucoma management","volume":"19","author":"Pardeshi","year":"2024","journal-title":"Discov. Nano"},{"key":"10.1016\/j.enzmictec.2025.110657_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1338528","article-title":"Carbonic anhydrase, its inhibitors and vascular function","volume":"11","author":"Garc\u00eda-Llorca","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib184","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","first-page":"157","article-title":"Membrane Associated Carbonic Anhydrase IV (CA IV): A Personal and Historical Perspective","author":"Waheed","year":"2014"},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib185","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib186","doi-asserted-by":"crossref","first-page":"2291336","DOI":"10.1080\/14756366.2023.2291336","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"Tsikas","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib187","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2015.11.006","article-title":"The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain","volume":"86","author":"Fossati","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib188","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/17425247.2012.711756","article-title":"Topical drug delivery systems in dermatology: a review of patient adherence issues","volume":"9","author":"Tan","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.enzmictec.2025.110657_bib189","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2165\/00002512-199710050-00006","volume":"10","author":"Balfour","year":"1997","journal-title":"Dorzolamide Drugs Aging"},{"issue":"3","key":"10.1016\/j.enzmictec.2025.110657_bib190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/OPTH.S3182","article-title":"Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension","volume":"2","author":"Iester","year":"2008","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib191","series-title":"Appetite Control","first-page":"433","article-title":"Weight-Reducing Side Effects of the Antiepileptic Agents Topiramate and Zonisamide","author":"Antel","year":"2012"},{"issue":"s1","key":"10.1016\/j.enzmictec.2025.110657_bib192","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1528-1157.2000.tb02169.x","article-title":"Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes","volume":"41","author":"Dodgson","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.enzmictec.2025.110657_bib193","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2500\/105065896781795003","article-title":"Carbonic anhydrase in human nasal epithelium: localization and effect of the inhibition by dichlorphenamide","volume":"10","author":"Cavaliere","year":"1996","journal-title":"Am. J. Rhinol."},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib194","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/13543776.2023.2245971","article-title":"Targeting carbonic anhydrases for the management of hypoxic metastatic tumors","volume":"33","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/metabo10100412","article-title":"Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.enzmictec.2025.110657_bib196","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.enzmictec.2025.110657_bib197","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/cancers12061616","article-title":"How and why are cancers acidic? Carbonic anhydrase IX and the homeostatic control of tumour extracellular pH","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.enzmictec.2025.110657_bib198","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1002\/alz.13063","article-title":"FDA-approved carbonic anhydrase inhibitors reduce amyloid \u03b2 pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness","volume":"19","author":"Canepa","year":"2023","journal-title":"Alzheimer'S. Dement."},{"issue":"15","key":"10.1016\/j.enzmictec.2025.110657_bib199","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms20153841","article-title":"Role of Carbonic Anhydrases and Inhibitors in Acid\u2013Base Physiology: Insights from Mathematical Modeling","volume":"20","author":"Occhipinti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.enzmictec.2025.110657_bib200","series-title":"Modern Medicinal Chemistry: Techniques and Applications","author":"Kumar","year":"2024"},{"key":"10.1016\/j.enzmictec.2025.110657_bib201","series-title":"Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection","first-page":"335","article-title":"Absorption, distribution, metabolism, excretion, and toxicity assessment of drugs using computational tools","author":"Sucharitha","year":"2022"},{"key":"10.1016\/j.enzmictec.2025.110657_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110372","article-title":"Phytochemical inhibitors of squalene epoxidase: Integrated In silico and In vitro mechanistic insights for targeting cholesterol biosynthesis","volume":"768","author":"Kamel","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.enzmictec.2025.110657_bib203","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/cancers15123233","article-title":"Dose optimization in oncology drug development: the emerging role of pharmacogenomics, pharmacokinetics, and pharmacodynamics","volume":"15","author":"Papachristos","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib204","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","article-title":"Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies","volume":"37","author":"Kciuk","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.enzmictec.2025.110657_bib205","doi-asserted-by":"crossref","first-page":"1479993","DOI":"10.3389\/fnano.2024.1479993","article-title":"Clinical applications and therapeutic potentials of advanced nanoparticles: a comprehensive review on completed human clinical trials","volume":"6","author":"Kumarasamy","year":"2024","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.enzmictec.2025.110657_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140609","article-title":"Mechanistic insights into alkaloid-based inhibition of squalene epoxidase: a combined in silico and experimental approach for targeting cholesterol biosynthesis","volume":"302","author":"Kamel","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.enzmictec.2025.110657_bib207","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/antibiotics12010142","article-title":"Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now?","volume":"12","author":"Nocentini","year":"2023","journal-title":"Antibiotics"},{"issue":"9","key":"10.1016\/j.enzmictec.2025.110657_bib208","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/acsmedchemlett.4c00284","article-title":"Study of chalcogen aspirin derivatives with carbonic anhydrase inhibitory properties for treating inflammatory pain","volume":"15","author":"Lucarini","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.enzmictec.2025.110657_bib209","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"issue":"39","key":"10.1016\/j.enzmictec.2025.110657_bib210","doi-asserted-by":"crossref","first-page":"28608","DOI":"10.1039\/D4RA04165H","article-title":"Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFR WT and EGFR T790M: integrating biological, molecular docking, and ADMET analysis","volume":"14","author":"Abd El-Lateef","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.enzmictec.2025.110657_bib211","series-title":"Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications","author":"Wu","year":"2024"},{"key":"10.1016\/j.enzmictec.2025.110657_bib212","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101401.3","article-title":"Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX","volume":"13","author":"Va\u0161kevi\u010dius","year":"2024","journal-title":"eLife"},{"issue":"8","key":"10.1016\/j.enzmictec.2025.110657_bib213","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20240130","article-title":"Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors","volume":"44","author":"Acharya","year":"2024","journal-title":"Biosci. Rep."},{"issue":"10","key":"10.1016\/j.enzmictec.2025.110657_bib214","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/carcin\/bgae057","article-title":"Allura red AC is a xenobiotic. Is it also a carcinogen?","volume":"45","author":"Hofseth","year":"2024","journal-title":"Carcinogenesis"}],"container-title":["Enzyme and Microbial Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141022925000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141022925000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:58:37Z","timestamp":1749085117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141022925000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":214,"alternative-id":["S0141022925000778"],"URL":"https:\/\/doi.org\/10.1016\/j.enzmictec.2025.110657","relation":{},"ISSN":["0141-0229"],"issn-type":[{"value":"0141-0229","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive insights into carbonic anhydrase inhibition: A triad of In vitro, In silico, and In vivo perspectives","name":"articletitle","label":"Article Title"},{"value":"Enzyme and Microbial Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.enzmictec.2025.110657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110657"}}